North Texas Veterans Healthcare System
40
3
4
23
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 40/100
12.5%
5 terminated/withdrawn out of 40 trials
82.1%
-4.4% vs industry average
40%
16 trials in Phase 3/4
9%
2 of 23 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (40)
Evaluating the Efficacy of a Vocational Counseling Intervention to Improve Occupational Functioning and Employment Quality Among Veterans With Mental Health and Substance Use Disorders
Role: collaborator
A Comparison of Prolonged Exposure Therapy, Pharmacotherapy, and Their Combination for PTSD
Role: collaborator
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer
Role: collaborator
Assessing the Efficacy of an Acceptance-Based Digital Intervention for Veterans With Chronic Pain
Role: collaborator
Tele-Collaborative Outreach to Rural Patients With Chronic Pain
Role: collaborator
Neural Control and Cardiac-Vascular Function in Women With PTSD (VA Psychological Assessment)
Role: lead
Mobile Health Strategies for Veterans
Role: collaborator
The LIVMOR Data Collection Study for the Development and Validation of L-1000AF System
Role: collaborator
Assessing Supported Employment With Veterans With Felony Convictions and Mental Illness or Substance Abuse
Role: collaborator
A Pilot Exercise Study for PTSD in Women Veterans
Role: lead
Excellence in Peripheral Arterial Disease Treatment of Superficial Femoral Artery Disease With Drug-eluting Stents
Role: lead
Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)
Role: lead
Outcomes in Femoropopliteal Disease Stratified by Translesional Pressure Gradient
Role: lead
Rapamycin as a Means of Interference With Reconsolidation of Posttraumatic Stress Disorder-related Traumatic Memory
Role: collaborator
Excellence In Peripheral Artery Disease Thrombin Receptor Antagonist Intervention In Claudication Evaluation (XLPAD-TRACE Trial)
Role: lead
Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD
Role: lead
Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" Trial
Role: lead
Multicenter LAser VA Registry of Percutaneous Coronary Interventions (LAVA)
Role: lead
Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis
Role: lead
Efficacy CompariSon of Pre-stenting Atherectomy Versus Scoring ballooN for calcifieD Coronary Lesions Coronary Lesions
Role: lead